New
Empaa-M 12.5mg/500mg Tablets (Empagliflozin + Metformin HCl)
Empaa-M 12.5mg/500mg Tablets (Empagliflozin + Metformin HCl)
Empaa-M 12.5mg/500mg Tablets (Empagliflozin + Metformin HCl)
Description
Empaa-M 12.5mg/500mg Tablets (Empagliflozin + Metformin HCl)
Empaa-M 12.5mg/500mg Tablets contain a fixed-dose combination of empagliflozin and metformin hydrochloride, indicated for the management of type 2 diabetes mellitus in adults. Empagliflozin reduces renal glucose reabsorption, while metformin improves insulin sensitivity and decreases hepatic glucose production to support glycemic control. This combination therapy is prescribed when dual-mechanism treatment is required under medical supervision. Empaa-M is commonly used in Pakistan as part of long-term diabetes management based on individual patient assessment. Oxygen Pharmacy ensures authentic sourcing, proper storage, and nationwide availability.
